Genentech has purchased OriGene Technologies, Inc.'s TrueClone Collection of full-length human cDNAs suitable for transfection and direct in vitro expression. OriGene cDNA clones are expression-ready, authentic full-length cDNA plasmids for use in target and lead identification and validation. The cDNAs allow scientists to easily query the roles of genes in disease phenotypes and pathways.

"OriGene's mission is to build the most comprehensive collection of human full-length cDNAs in expression-ready vectors and to make this collection available to all researchers for systematic studies of human gene functions," said Karl Kovacs Ph.D., vice president of Alliance Management at OriGene. "We are glad to see our clones involved in the highly innovative research at Genentech."